Impact of heart rate variability on C-reactive protein concentrations in Japanese adult nonsmokers: The Toon Health Study

Atherosclerosis

Volumn 244, Issue , 2016, Pages 79-85

  Saito, Isao ^a   Hitsumoto, Shinich ^b   Maruyama, Koutatsu ^c   Eguchi, Eri ^d   Kato, Tadahiro ^e   Okamoto, Ai ^b   Kawamura, Ryoichi ^a   Takata, Yasunori ^a   Nishida, Wataru ^a   Nishimiya, Tatsuya ^b   Onuma, Hiroshi ^a   Osawa, Haruhiko ^a   Tanigawa, Takeshi ^c  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e EHIME UNIVERSITY   (Japan)

Author keywords

Epidemiology; Heart rate variability; Inflammation; Insulin sensitivity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; ASSOCIATION; BODY MASS; BODY WEIGHT; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; JAPANESE (PEOPLE); LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGE DISTRIBUTION; ATHEROSCLEROSIS; BLOOD; CIRCADIAN RHYTHM; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; ELECTROCARDIOGRAPHY; FOLLOW UP; HEALTH SURVEY; HEART RATE; INFLAMMATION; INSULIN RESISTANCE; JAPAN; METABOLISM; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TRENDS;

ADULT; AGE DISTRIBUTION; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HEART RATE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; JAPAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84946925639     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.10.112     Document Type: Article

References (26)

1. Liao D., Carnethon M., Evans G.W., Cascio W.E., Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes 2002, 51:3524-3531.
2. Singh J.P., Larson M.G., Tsuji H., Evans J.C., O'Donnell C.J., Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham heart study. Hypertension 1998, 32:293-297.
3. Schroeder E.B., Chambless L.E., Liao D., Prineas R.J., Evans G.W., Rosamond W.D., et al. Diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 2005, 28:668-674.
4. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the european society of cardiology and the north american society of pacing and electrophysiology. Eur. Heart J. 1996, 17:354-381.
5. Ridker P.M. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul. Fibrinolysis 1999, 10(Suppl. 1):S9-S12.
6. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
7. Choi J., Joseph L., Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes. Rev. 2013, 14:232-244.
8. Gupta N.K., de Lemos J.A., Ayers C.R., Abdullah S.M., McGuire D.K., Khera A. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study. J. Am. Coll. Cardiol. 2012, 60:1148-1155.
9. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
10. Haarala A., Kahonen M., Eklund C., Jylhava J., Koskinen T., Taittonen L., et al. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study. Eur. J. Clin. Invest. 2011, 41:951-957.
11. Thayer J.F., Fischer J.E. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J. Intern. Med. 2009, 265:439-447.
12. Sloan R.P., McCreath H., Tracey K.J., Sidney S., Liu K., Seeman T. Rr interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. 2007, 13:178-184.
13. Jarczok M.N., Koenig J., Mauss D., Fischer J.E., Thayer J.F. Lower heart rate variability predicts increased level of C-reactive protein 4 years later in healthy, nonsmoking adults. J. Intern. Med. 2014, 276:667-671.
14. Lautt W.W. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J. Pharm. Sci. 2004, 95:9-17.
15. Ribeiro R.T., Lautt W.W., Legare D.J., Macedo M.P. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 2005, 48:976-983.
16. Cooper T.M., McKinley P.S., Seeman T.E., Choo T.H., Lee S., Sloan R.P. Heart rate variability predicts levels of inflammatory markers: evidence for the vagal anti-inflammatory pathway. Brain Behav. Immun. 2015, 49:94-100.
17. Saito I., Sato S., Nakamura M., Kokubo Y., Mannami T., Adachi H., et al. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-collaborative inflammation cohort (JNIC) study. Atherosclerosis 2007, 194:238-244.
18. Nakamura M., Koyama I., Iso H., Sato S., Okazaki M., Kiyama M., et al. Measurement performance of reagent manufacturers by centers for disease control and prevention/cholesterol reference method laboratory network lipid standardization specified for metabolic syndrome-focused health checkups program in Japan. J. Atheroscler. Thromb. 2009, 16:756-763.
19. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Kumar M., Czarnecki E.M., et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res. Clin. Pract. 2000, 47:177-184.
20. Saito I., Hitsumoto S., Maruyama K., Nishida W., Eguchi E., Kato T., et al. Heart rate variability, insulin resistance, and insulin sensitivity in Japanese adults: the Toon Health Study. J. Epidemiol. 2015, 25:583-591.
21. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
22. Chambers J.C., Eda S., Bassett P., Karim Y., Thompson S.G., Gallimore J.R., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in indian asians from the united kingdom compared with european whites. Circulation 2001, 104:145-150.
23. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000, 102:42-47.
24. Emerging Risk Factors C, Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
25. Dehghan A., Dupuis J., Barbalic M., Bis J.C., Eiriksdottir G., Lu C., et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011, 123:731-738.
26. Saito I., Maruyama K., Eguchi E. C-reactive protein and cardiovascular disease in East Asians: a systematic review. Clin. Med. Insights Cardiol. 2014, 8:35-42.